Association of a polymorphism near CREB1 with differential aversion processing in the insula of healthy participants

Archives of General Psychiatry

Volumn 65, Issue 8, 2008, Pages 882-892

  Perlis, Roy H ^a   Holt, Daphne J ^a   Smoller, Jordan W ^a   Blood, Anne J ^a   Lee, Sang ^a   Kim, Byoung Woo ^a   Lee, Myung Joo ^a   Sun, Mei ^a   Makris, Nikos ^a   Kennedy, David K ^a   Rooney, Kathryn ^a   Dougherty, Darin D ^a   Hoge, Rick ^a,b   Rosenbaum, Jerrold F ^a   Fava, Maurizio ^a   Gusella, James ^a   Gasic, Gregory P ^a   Breiter, Hans C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;

ADULT; AMYGDALOID NUCLEUS; ANGER; ARTICLE; AVERSION; AVOIDANCE BEHAVIOR; BLOOD OXYGENATION; BRAIN FUNCTION; CAUCASIAN; CINGULATE GYRUS; CONTROLLED STUDY; EMOTION; FACIAL EXPRESSION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; INSULA; MALE; NERVE CELL NETWORK; NORMAL HUMAN; ORBITAL CORTEX; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; TASK PERFORMANCE;

ADULT; ALLELES; ANGER; AROUSAL; AVOIDANCE LEARNING; CEREBRAL CORTEX; CHOICE BEHAVIOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOMINANCE, CEREBRAL; FACIAL EXPRESSION; FEMALE; GENOTYPE; HOSTILITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINKAGE DISEQUILIBRIUM; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; NERVE NET; OXYGEN; PATTERN RECOGNITION, VISUAL; PERSONALITY INVENTORY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOMOTOR PERFORMANCE; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 48949100399     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2008.3     Document Type: Article

References (69)

1. Becerra L, Breiter HC, Wise R, Gonzalez RG, Borsook D. Reward circuitry activation by noxious thermal stimuli. Neuron. 2001;32(5):927-946.
2. Breiter HC, Aharon I, Kahneman D, Dale A, Shizgal P. Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron. 2001;30(2):619-639.
3. Breiter HC, Gasic GP, Makris N. Imaging the neural systems for motivated behavior and their dysfunction in neuropsychiatric illness. In: Deisboeck TS, Kresh JY, eds. Complex Systems Science in Biomedicine. New York, NY: Springer Verlag; 2006:763-810.
4. Aharon I, Etcoff N, Ariely D, Chabris CF, O'Connor E, Breiter HC. Beautiful faces have variable reward value: fMRI and behavioral evidence. Neuron. 2001;32(3):537-551.
5. Strauss MM, Makris N, Aharon I, Vangel MG, Goodman J, Kennedy DN, Gasic GP, Breiter HC. fMRI of sensitization to angry faces. Neuroimage. 2005;26(2):389-413.
6. Breiter HC, Etcoff NL, Whalen PJ, Kennedy WA, Rauch SL, Buckner RL, Strauss MM, Hyman SE, Rosen BR. Response and habituation of the human amygdala during visual processing of facial expression. Neuron. 1996;17(5):875-887.
7. Morris JS, Frith CD, Perrett DI, Rowland D, Young AW, Calder AJ, Dolan RJ. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature. 1996;383(6603):812-815.
8. Phillips ML, Young AW, Scott SK, Calder AJ, Andrew C, Giampietro V, Williams SC, Bullmore ET, Brammer M, Gray JA. Neural responses to facial and vocal expressions of fear and disgust. Proc Biol Sci. 1998;265(1408):1809-1817.
9. Whalen PJ, Rauch SL, Etcoff NL, McInerney SC, Lee MB, Jenike MA. Masked presentations of emotional facial expressions modulate amygdala activity without explicit knowledge. J Neurosci. 1998;18(1):411-418.
10. Hariri AR, Mattay VS, Tessitore A, Kolachana B, Fera F, Goldman D, Egan MF, Weinberger DR. Serotonin transporter genetic variation and the response of the human amygdala. Science. 2002;297(5580):400-403.
11. Nitschke JB, Sarinopoulos I, Mackiewicz KL, Schaefer HS, Davidson RJ. Functional neuroanatomy of aversion and its anticipation. Neuroimage. 2006;29(1):106-116.
12. Paulus MP, Stein MB. An insular view of anxiety. Biol Psychiatry. 2006;60(4):383-387.
13. LeDoux J. The emotional brain, fear, and the amygdala. Cell Mol Neurobiol. 2003;23(4-5):727-738.
14. Reynolds SM, Zahm DS. Specificity in the projections of prefrontal and insular cortex to ventral striatopallidum and the extended amygdala. J Neurosci. 2005;25(50):11757-11767.
15. Ongür D, Price JL. The organization of networks within the orbital and medial prefrontal cortex of rats, monkeys and humans. Cereb Cortex. 2000;10(3):206-219.
16. McClung CA, Nestler EJ. Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci. 2003;6(11):1208-1215.
17. Shaw-Lutchman TZ, Impey S, Storm D, Nestler EJ. Regulation of CRE-mediated transcription in mouse brain by amphetamine. Synapse. 2003;48(1):10-17.
18. Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ. Regulation of cocaine reward by CREB. Science. 1998;282(5397):2272-2275.
19. Self DW, Genova LM, Hope BT, Barnhart WJ, Spencer JJ, Nestler EJ. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci. 1998;18(5):1848-1859.
20. Widnell KL, Self DW, Lane SB, Russell DS, Vaidya VA, Miserendino MJ, Rubin CS, Duman RS, Nestler EJ. Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J Pharmacol Exp Ther. 1996;276(1):306-315.
21. Guitart X, Thompson MA, Mirante CK, Greenberg ME, Nestler EJ. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J Neurochem. 1992;58(3):1168-1171.
22. Pandey SC, Zhang H, Roy A, Xu T. Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism. J Clin Invest. 2005;115(10):2762-2773.
23. Barrot M, Olivier JD, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ, Impey S, Storm DR, Neve RL, Yin JC, Zachariou V, Nestler EJ. CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci U S A. 2002;99(17):11435-11440.
24. Barrot M, Wallace DL, Bolaños CA, Graham DL, Perrotti LI, Neve RL, Chambliss H, Yin JC, Nestler EJ. Regulation of anxiety and initiation of sexual behavior by CREB in the nucleus accumbens. Proc Natl Acad Sci U S A. 2005;102(23):8357-8362.
25. Dwivedi Y, Rao JS, Rizavi HS, Kotowski J, Conley RR, Roberts RC, Tamminga CA, Pandey GN. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry. 2003;60(3):273-282.
26. Pandey GN, Dwivedi Y, Ren X, Rizavi HS, Roberts RC, Conley RR. Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus. Int J Neuropsychopharmacol. 2006;10(5):621-629.
27. Perlis RH, Purcell S, Fagerness J, Cusin C, Yamaki L, Fava M, Smoller JW. Clinical and Genetic Dissection of Anger Expression and CREB1 Polymorphisms in Major Depressive Disorder. Biol Psychiatry. 2007;62(5):536-540.
28. Perlis RH, Purcell S, Fava M, Fagerness J, Rush AJ, Trivedi MH, Smoller JW. Association between treatment-emergent suicidal ideation with citalopram and polymorphisms near cyclic adenosine monophosphate response element binding protein in the STAR*D study. Arch Gen Psychiatry. 2007;64(6):689-697.
29. Meyer-Lindenberg A, Weinberger DR. Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci. 2006;7(10):818-827.
30. First MB, Spitzer R, Gibbon M. Structured Clinical Interview for DSM-IV Axis I Disorders. New York, NY: Biometrics Research Department, New York State Psychiatric Institute; 1996.
31. Benson V, Marano MA. Current estimates from the National Health Interview Survey, 1995. Vital Health Stat 10. 1998;(199):1-428.
32. Bernstein IH, Rush AJ, Carmody TJ, Woo A, Trivedi MH. Clinical vs. self-report versions of the quick inventory of depressive symptomatology in a public sector sample. J Psychiatr Res. 2007;41(3-4):239-246.
33. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583.
34. Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971;9(1):97-113.
35. Kellner R. A symptom questionnaire. J Clin Psychiatry. 1987;48(7):268-274.
36. Ekman P, Friesen W. Pictures of Facial Affect. Palo Alto, CA: Consulting Psychologists Press; 1976.
37. Deichmann R, Gottfried JA, Hutton C, Turner R. Optimized EPI for fMRI studies of the orbitofrontal cortex. Neuroimage. 2003;19(2, pt 1):430-441.
38. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G, Jones I, Owen M, Craddock N, DePaulo JR, Lander ES. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus: brain-derived neutrophic factor. Mol Psychiatry. 2002;7(6):579-593.
39. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J, Little DP, Strausberg R, Koester H, Cantor CR, Braun A. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci U S A. 2001;98(2):581-584.
40. Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD. Detecting activations in PET and fMRI: levels of inference and power. Neuroimage. 1996;4(3, pt 1):223-235.
41. Siegel S. Nonparametric Statistics for the Behavioral Sciences. New York, NY: McGraw-Hill; 1956.
42. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, Small GW. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med. 2000;343(7):450-456.
43. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98(12):6917-6922.
44. Wassink TH, Nelson JJ, Crowe RR, Andreasen NC. Heritability of BDNF alleles and their effect on brain morphology in schizophrenia. Am J Med Genet. 1999;88(6):724-728.
45. Filipek PA, Richelme C, Kennedy DN, Caviness VS Jr. The young adult human brain: an MRI-based morphometric analysis. Cereb Cortex. 1994;4(4):344-360.
46. Makris N, Worth AJ, Sorensen AG, Papadimitriou GM, Wu O, Reese TG, Wedeen VJ, Davis TL, Stakes JW, Caviness VS, Kaplan E, Rosen BR, Pandya DN, Kennedy DN. Morphometry of in vivo human white matter association pathways with diffusion-weighted magnetic resonance imaging. Ann Neurol. 1997;42(6):951-962.
47. Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD, Goodman JM, Kantor HL, Gastfriend DR, Riorden JP, Mathew RT, Rosen BR, Hyman SE. Acute effects of cocaine on human brain activity and emotion. Neuron. 1997;19(3):591-611.
48. Caviness VS Jr, Kennedy DN, Richelme C, Rademacher J, Filipek PA. The human brain age 7-11 years: a volumetric analysis based on magnetic resonance images. Cereb Cortex. 1996;6(5):726-736.
49. Makris N, Meyer JW, Bates JF, Yeterian EH, Kennedy DN, Caviness VS. MRIBased topographic parcellation of human cerebral white matter and nuclei II: rationale and applications with systematics of cerebral connectivity. Neuroimage. 1999;9(1):18-45.
50. Makris N, Gasic GP, Seidman LJ, Goldstein JM, Gastfriend DR, Elman I, Albaugh MD, Hodge SM, Ziegler DA, Sheahan FS, Caviness VS Jr, Tsuang MT, Kennedy DN, Hyman SE, Rosen BR, Breiter HC. Decreased absolute amygdala volume in cocaine addicts. Neuron. 2004;44(4):729-740.
51. Wright CI, Fischer H, Whalen PJ, McInerney SC, Shin LM, Rauch SL. Differential prefrontal cortex and amygdala habituation to repeatedly presented emotional stimuli. Neuroreport. 2001;12(2):379-383.
52. Britton JC, Taylor SF, Sudheimer KD, Liberzon I. Facial expressions and complex IAPS pictures: common and differential networks. Neuroimage. 2006;31(2):906-919.
53. Grosbras MH, Paus T. Brain networks involved in viewing angry hands or faces. Cereb Cortex. 2006;16(8):1087-1096.
54. Ploghaus A, Tracey I, Gati JS, Clare S, Menon RS, Matthews PM, Rawlins JN. Dissociating pain from its anticipation in the human brain. Science. 1999;284(5422):1979-1981.
55. Rauch SL, Savage CR, Alpert NM, Fischman AJ, Jenike MA. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry. 1997;42(6):446-452.
56. Lorberbaum JP, Kose S, Johnson MR, Arana GW, Sullivan LK, Hamner MB, Ballenger JC, Lydiard RB, Brodrick PS, Bohning DE, George MS. Neural correlates of speech anticipatory anxiety in generalized social phobia. Neuroreport. 2004;15(18):2701-2705.
57. Stein DJ, Arya M, Pietrini P, Rapoport JL, Swedo SE. Neurocircuitry of disgust and anxiety in obsessive-compulsive disorder: a positron emission tomography study. Metab Brain Dis. 2006;21(2-3):267-277.
58. Knutson B, Rick S, Wimmer GE, Prelec D, Loewenstein G. Neural predictors of purchases. Neuron. 2007;53(1):147-156.
59. Kuhnen CM, Knutson B. The neural basis of financial risk taking. Neuron. 2005;47(5):763-770.
60. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr. Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci. 2001;21(18):7397-7403.
61. Chartoff EH, Papadopoulou M, Konradi C, Carlezon WA Jr. Dopamine-dependent increases in phosphorylation of cAMP response element binding protein (CREB) during precipitated morphine withdrawal in primary cultures of rat striatum. J Neurochem. 2003;87(1):107-118.
62. Chartoff EH, Mague SD, Barhight MF, Smith AM, Carlezon WA Jr. Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. J Neurosci. 2006;26(24):6450-6457.
63. Glimcher PW, Dorris MC, Bayer HM. Physiological utility theory and the neuroeconomics of choice. Games Econ Behav. 2005;52(2):213-256.
64. Glimcher PW, Rustichini A. Neuroeconomics: the consilience of brain and decision. Science. 2004;306(5695):447-452.
65. Coven E, Ni Y, Widnell KL, Chen J, Walker WH, Habener JF, Nestler EJ. Cell type-specific regulation of CREB gene expression: mutational analysis of CREB promoter activity. J Neurochem. 1998;71(5):1865-1874.
66. Wu J, Xie X. Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol. 2006;7(9):R85.
67. The International HapMap Consortium. The International HapMap Project. Nature. 2003;426(6968):789-796.
68. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, Tyler-Smith C, Carter N, Scherer SW, Tavaré S, Deloukas P, Hurles ME, Dermitzakis ET. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 2007;315(5813):848-853.
69. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MMA. "Silent" polymorphism in the MDR1 gene changes substrate specificity. Science. 2007;315(5811):525-528.